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In 1916, Douglas and Colebrook noted that blood coagulation was 
accelerated by the addition of trypsin.  A year later, Heard reported 
that trypsin could actually coagulate oxalated blood, and ascribed the 
phenomenon to a hypothetical disturbance in the Ca and P content of 
the  fibrinogen,  induced by  the  enzyme.  These  two  reports  were 
apparently  overlooked  by  workers  in  the  field.  In  1928, Wald- 
schmidt-Leitz and his coworkers also reported that trypsin accelerated 
blood coagulation.  They considered their experiments to prove that 
thrombin was a  proteolytic enzyme either identical with or closely 
related to trypsin; that coagulation was due to the enzymic hydrolysis 
of fibrinogen to  an  insoluble modification; and  that  trypsin  accel- 
erated coagulation insofar as it hastened this hydrolysis.  They found 
other proteolytic enzymes, including papain, to be inactive. 
Mellanby  (1935 b)  re-investigated  the action of  trypsin on blood 
plasma and concluded that the coagulation observed by Heard was 
due simply to  traces of calcium in the commercial preparations  of 
trypsin, and was wholly unrelated to the enzyme as such. 
The  present  observations  grew  out  of  a  chance  re-discovery of 
Heard's observation: certain mixtures of citrated horse plasma and 
trypsin  were  found  to  have  clotted  when  examined  after  several 
hours.  The  participation  of  calcium could be  excluded.  Human, 
guinea pig, dog, horse, and rabbit plasma or blood could be similarly 
coagulated, provided only that  one used  the  correct concentration 
of trypsin.  Since the phenomenon promised to throw considerable 
light on the mechanism of physiological coagulation, it was studied 
in some detail. 
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In addition  to trypsin, papain was also found capable of initiating 
coagulation,  but  by  a  different mechanism.  The  latter  is  a  true 
thrombin, insofar as it acts directly on fibrinogen to form an insoluble 
modification resembling fibrin.  Trypsin, however, does not coagulate 
fibrinogen,  but  apparently  reacts with  plasma prothrombin  to  form 
the physiological coagulant thrombin. 
Methods  and Materials 
We are indebted to the Mulford Biological  Laboratories at Glenolden  for the 
citrated horse blood used in most of the experiments.  The crude trypsin was the 
Digestive Ferments Company's "Trypsin 1:110," and the papain was a powder 
supplied by Merck.  Both preparations were quite acid, and the suspensions  in 
salt solution had to be cautiously neutralized before using.  The suspended solids 
in such neutralized preparations were found to be relatively inert and could be 
removed by centrifugation. 
We are deeply indebted to Dr. John H. Northrop of The Rockefeller Institute 
for Medical Research at Princeton for a most generous supply of crystalline trypsin 
for use in these experiments.  It is to be noted that the concentrations mentioned 
in the text are those of the dry powder; and this contains approximately 60 per 
cent MgSO4. 
Preparation of Prothromb/n.--The precipitation of water-diluted plasma with 
acetic acid as described by Mellanby  (1931) proved to be simple and to yield 
a more active product than the similar precipitation with CO2 described by Eagle 
(1935a) in ignorance of the former procedure. 
Plasma was diluted with 15 volumes of cold (0-5  °) water, and N/1 acetic acid 
was added until  the precipitate became visibly granular.  Usually, an amount 
of acid corresponding to 1/20 the original plasma volume suflficed. 
The centrifuged precipitate was dissolved in  0.85  per cent  NaCl up  to the 
original plasma volume, and neutralized cautiously with either N/1  Na2 CO8 or 
NaOH solution.  The resultant opalescent solution contained fibrinogen,  which 
could be removed by heating at 56  ° for 3-5 minutes, with little or no decrease in 
prothrombin activity of the solution (Eagle (1935a)). 
Alternatively, the prothrombin was purified by the MeUanby technic.  The 
original acetic acid precipitate was suspended in water in a volume corresponding 
to 1/2 the original plasma volume, and this suspension then diluted with an equal 
volume of a  1/10 dilution of saturated Ca (OH)~ previously brought to pH 7.0 
with CO2.  After 10 minutes, the mixture was centrifuged and the supernatant 
fluid, containing a large proportion of the prothrombin and little or no fibrinogen, 
was rendered isotonic by the addition of 1/20 volume of 17 per cent NaC1. 
Preparation of Fibrinogen.--Repeated precipitations (three to four)  with  1.5 
volumes of saturated NaCI yielded a satisfactory product which failed to coagulate 
on the addition of Ca and tissue extracts, but was promptly coagulated on the HARRY EAGLE  AND  TZVEE  N.  HARRIS  ,545 
addition of thrombin.  The final product was brought to a  concentration of 0.9 
per cent with respect to NaCI by proper dilution. 
Quantitative  Estimation  of Thrombin  Activity.--The  time required 
for a given solution of thrombin to cause the coagulation of fibrinogen 
under standard conditions of temperature, volume, and salt concen- 
tration, was used as a  criterion of its activity, and could be compared 
with  the  activity  of  other  solutions  by  interpolation  on  a  curve 
correlating  coagulation  time  with  thrombin  concentration  (Eagle 
(1935a)). 
TABLE  I 
The Coagulation of Citrated Plasma by Trypsin 
Coagulation time of 0.6 cc. plasma +  varying quantities of trypsin solution 
in a total volume of 1 cc. 
Plasma 
Rabbit 
Guinea pig 
Human 
Horse 
l~ev ceta 
10 
10 
10 
7 
Amount of trypsin solution, co. 
0.4 
oo 
oo 
Go 
0.2 
Go 
8 rain. 
Go 
co 
0.1  0.05 
rain.  .*in. 
1  t 
7  4 
8  5 
7½  6 
0.025  0.0125 
rain.  rain. 
1  5 
5½  - 
3  4½ 
6  16 
0.0062 
rain. 
35 
14 
6O 
0.0031 
* "Difco 110" dissolved in salt solution.  The results were unaffected by pre- 
liminary dialysis of the enzyme solution to remove possible calcium. 
t No clot in 24 hrs. 
The Coagulation of Blood or Plasma by Trypsin 
A  typical experiment which illustrates the fact that coagulation is 
observed  only  within  a  comparatively  narrow  optimum  zone  of 
trypsin concentration is given in Table I.  That the clot results from 
the precipitation of the fibrinogen as a  fibrillar gel resembling fibrin 
is clearly  indicated by  the  following observations:  (1)  plasma from 
which the  fibrinogen  is  removed by  heating  for  5  minutes  at  56  °, 
or by half saturation with NaC1, can no longer be coagulated by the 
enzyme; (2)  the  supernatant  fluid  expressed from the  clot contains 
no fibrinogen, as shown by heating to 56  °, or by half saturation with 
NaCI; moreover, it no longer clots on the addition of either Ca or 546  BLOOD  COAGULATION.  V 
thrombln in sufficient concentration to coagulate the original plasma; 
(3) the clot is microscopically indistinguishable from that which forms 
physiologically. 
The  participation  of  calcium  in  the  coagulation  of  plasma  by 
trypsin was rendered improbable by the fact  that  coagulation was 
observed in trypsin: plasma mixtures containing so much citrate and 
so little trypsin that  even had the latter consisted solely of CaCl~, 
no coagulation would have been observed.  Moreover, the coagulat- 
ing activity of the trypsin was quantitatively unaffected by previous 
dialysis. 
Definitive  proof  that  the  observed  coagulation  was  due  to  the 
trypsin per se, rather than adventitious substances such as Ca, was 
furnished by the fact that crystalline trypsin (Northrop and Kunitz) 
also caused coagulation of citrated blood or plasma, and was approxi- 
mately 20 to 50 times as active in this respect as the crude trypsin. 
It is true that the crystalline enzyme preparation contained MgS04: 
but the latter,  in any concentration, failed to  cause coagulation of 
citrated horse plasma; and if the trypsin was dialyzed against distilled 
water  until it  contained no demonstrable free  SO,,  its  coagulating 
activity was found to have been quantitatively unaffected. 
The  Mechanism  of the  Trypsin  Effect.--Physiological  coagulation 
involves two consecutive reactions.  In the first of these, a  plasma 
factor (prothrombin) is activated by Ca and platelets  (or tissue ex- 
tracts)  to form thrombin; subsequently, this thrombin reacts with 
fibrinogen to  form fibrin.  It  becomes of interest  to ascertain  how 
trypsin causes coagulation: whether it replaces one or more of these 
physiological reagents, or  whether the phenomenon is wholly unre- 
lated to the physiological transformation of fibrinogen to fibrin. 
Trypsin was found to have no direct coagulative action on purified 
fibrinogen.  In  sufficient excess,  the  enzyme digested  the  protein, 
and rendered it incoagulable even by thrombin: but no clots were 
produced when trypsin in any concentration was mixed with fibrino- 
gen  (cf.  Table  IV).  Contrary  to  the  thesis  of  Waldschmidt-Leitz 
and coworkers, trypsin is therefore not analogous to thrombin. 
Instead, the coagulating action of trypsin was found to rest on the 
fact  that  it  reacts  with  prothrombin to  form  thrombin; and  this 
thrombin then acts on fibrinogen to form fibrin.  If one adds varying HARRY  EAGLE  AND  TZVEE  N. HARRIS  547 
amounts of trypsin to a solution of prothrombin, and tests the coagu- 
lating properties of the mixture at intervals by adding aliquot por- 
tions  to  purified  fibrinogen,  one  obtains  results  similar  to  those 
illustrated in Fig.  1.  With too little trypsin, there is no formation 
of thrombin.  There follows an intermediate range of concentrations, 
in which a relatively slight increase in the amount of trypsin causes a 
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FIG. 1. The formation of thrombin from prothrombin by trypsin.  Varying 
amounts of 1/15 per cent crystalline trypsin were added to 2 cc. of prothrombin 
solution.  Aliquot  portions were withdrawn at intervals and tested for thrombin 
content.  A similar experiment was carried out, using CaCI~ and tissue extract 
instead of trypsin as the activating agent. 
disproportionate increase in the amount of thrombin formed.  At a 
sharply  defined  optimum  there  is  the  rapid  formation of  a  large 
amount of thrombin.  This is usually between ½ and  ]  the mount 
formed from the same prothrombin by Ca and tissue extract; but in 
some experiments the two thrombins are of approximately the same 
activity.  With an excess of the enzyme, no thrombin formation can 548  BLOOD  COAGULATION.  V 
Protocol  1 
Thrombin is rapidly destroyed by the concentrations of trypsin necessary 
for the activation of prothrombin (Fig. 2). 
To 1.6 cc. of horse thrombin (prothrombin +  Ca  +  lung extract) were added 
0.4 ce. of ~/10 phosphate buffers and varying amounts of trypsin.  The thrombin 
activity of the mixtures was tested at intervals by adding aliquot portions to 0.4 ce. 
fibrinogen and noting the coagulation time.  The curves given in Fig. 2 represent 
the amount of residual thrombin after 5 minutes.  The results at pH 6.5, 6.2, 5.9, 
P6r ¢~r~ 
I 
OJ  0.2  03 
C¢. 
Crystalline  trypsin,  ]~  percent 
to  1.6~ horse thrombin ~lut~ 
Fro. 2.  Thrombin is rapidly destroyed by the concentrations of trypsin neces- 
sary for the activation of prothrombin. 
and 5.6 are not given, as they are practically identical with the curve at pH 6.8. 
The dotted curve in the figure represents  the amount of thrombin formed from 
the same prothrombin in  15 minutes by varying amounts of trypsin:  and it  is 
apparent that at the effective concentrations, thrombin is being destroyed almost 
as fast as it is formed. 
In this experiment,  as in that of Protocol 2, the pK' of the phosphate buffer 
was arbitrarily taken as 6.8.  The pH values given in the figures and tables are 
therefore in error to the extent that  the pK' of the several buffer-salt mixtures 
deviates from 6.8 because of their varying ionic strength. HARRY  EAGLE  AND  TZVEE  N.  HARRIS  549 
be demonstrated, because of the digestion of prothrombin, thrombin, 
or both.  It is to be noted that the thrombin formed at the optimum 
trypsin  concentration is  eventually similarly digested, and is  often 
no longer demonstrable after 1 or 2 hours. 
The formation and destruction of thrombin proceed simultaneously 
(Protocol 1 and Fig. 2); and the amount of thrombin demonstrated 
at any one time is a  resultant of the two processes.  As is shown in 
Fig.  1, Table III, and Fig.  2,  this destruction is quite rapid at the 
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FIG. 3. The reaction between prothrombin  and trypsin  to form thrombin. 
Showing the linear correlation between the amount  of prothrombin  used, the 
optimum concentration of trypsin, and the amount of thrombin formed at the 
optimum trypsin/prothrombin  ratio. 
optimum concentrations of trypsin,  and explains the fact that  the 
amount of thrombin elaborated by trypsin is usually only a  fraction 
of that formed on the addition of Ca and tissue extract to the same 
prothrombin  solution. 
The quantitative relationships between the amount of prothrombin 
solution  used,  the  amount of thrombin  formed, and  the  optimum 
concentration of trypsin are illustrated in Fig. 3.  As is there shown, 
there is a  linear  relationship between all  three factors.  The more 550  BLOOD  COAGULATION.  V 
prothrombin used,  the more thrombin is formed, and  the  greater is 
the  amount  of  trypsin  necessary  to  effect  the  transformation.  Be- 
cause of the progressive digestion of thrombin at the higher concen- 
TABLE II 
The Formation of Thrombin from Prothrombin by  Trypsin Is Independent of the 
Presence or Absence of Tissue Extracts, Unlike the Physiological 
Transformation by Ca 
To 2 co. of prothrombin prepared  from Berkefeld-fdtered  horse  plasma  were 
added varying quantities  of lung extract* and of crystalline  trypsin, as  indicated 
in the table.  The numbers in the body of this table represent the relative amounts 
of thrombin formSd.  A control experiment  using CaC12 instead of trypsin is also 
included. 
Tissue 
extract 
¢¢° 
0.2 
0.04 
0.008 
0 
0.2 
0.04 
0. 008 
0 
0.2 
0.04 
0.008 
0 
Time of 
incubafio~ 
mln. 
10 
2O 
60 
0.2 
100 
100 
100 
100 
35 
25 
25 
25 
10 
3 
1-2 
1-2 
Relative amount of thrombin formed on addition of 
Crystalline  trypsin, 1/15 per cent cc. 
0.15  .1 
60  6 
50  6 
5O  0 
50  8 
60  6 
60  6 
60 
60  6 
50  4 
50  4 
50  4 
50  4 
0 075 
3 
3 
3 
3 
3 
3 
3 
3 
k0! 
m__ 
CaCh, 0.2 
cc. of 0.I 
solution 
125 
50 
10 
0 
9~100 
15 
2-3 
90 
80 
25 
3 
* An aqueous  extract of rabbit lung tissue,  previously  washed  free of blood, 
minced, and kept frozen until needed.  Such extracts contained  no demonstrable 
prothrombin or fibrinogen.  The tissue  extract  could be replaced  by a  washed 
platelet  suspension,  which  yielded  the  same  results:  a  marked  acceleration  of 
thrombin formation in the presence of Ca, but no effect on thrombin formation 
by trypsin. 
trations of trypsin, the exact shape of the curves will vary according 
to  the  time  interval  allowed.  Thus,  if  the  experiment  of  Fig.  3 
were  terminated  after  15  minutes  instead  of  90  minutes,  each  of HARRY  EAGLE  AND  TZVEE  N.  HARRIS  551 
the curves would be higher, and would be shifted to the right  (less 
destruction of thrombin by  the trypsin): but the  relationships be- 
tween  prothrombin,  thrombin,  and  trypsin  there  indicated  would 
still hold. 
The  optimum concentration of  trypsin is  determined largely  by 
the protein content of the prothrombin solution.  The addition  to 
the latter of inert  serum,  containing no demonstrable thrombln or 
prothrombin, causes a  proportionate shift in the amount of trypsin 
necessary for thrombin formation.  The important factor  is  appar- 
ently  the  amount of  trypsin per unit protein; and the progressive 
shift in  the optimum trypsin  concentration as  the amount of pro- 
thrombin solution is increased  (Fig. 3)  is an expression of this fact. 
The reaction between trypsin and prothrombin is independent of 
the  presence  of  either  Ca,  platelets,  or  tissue  extractives.  Pro- 
thrombin prepared from Berkefeld-fdtered plasma,  and which con- 
tains neither Ca nor tissue extractive, is readily activated by trypsin; 
moreover, the rate of activation and the amount of thrombin formed 
are  not  affected by  the  addition of  even  large  amounts of  tissue 
extract (Table II). 
An attempt to  determine the  optimum pH  for  the  trypsin-pro- 
thrombin reaction is summarized in Protocol 2  and Table III.  As 
is there shown, the higher the concentration of trypsin, the more acid 
is the apparent pH  optimum; and this dependence on the  trypsin 
concentration is  accentuated if the .trypsin-prothrombin mixture is 
allowed to  incubate for  some time before the  thrombin content is 
determined.  The  discrepancy is  explained by  the  data  of  Fig.  2. 
Thrombin is rapidly destroyed only by the higher concentrations of 
trypsin; and this destruction proceeds more rapidly in  the alkaline 
range than it does at pH 6.8 or 6.5, causing an acid shift in the ap- 
parent optimum pH for thrombin production.  The  experiment of 
Table  III therefore offers no clue as to  the true pH  optimum for 
thrombin  production  by  trypsin;  but  indicates  instead  how  the 
amount of net free thrombin varies with pH, trypsin concentration, 
and time. 
That  the  coagulant produced by  the  interaction of  trypsin  and 
solutions of prothrombin is actually thrombin would seem to require 
no proof. It is nevertheless of interest to note that if one adds trypsin 552  BLOOD COAGULATION.  V 
Protocol 2 
The effect of pH on the trypsin-prothrombin reaction (Table III). 
To  1.6  cc.  of horse prothrombin  solution  (heated  at  56°C.  for 5 minutes to 
remove fibrinogen) were added 0.4 cc. of ~/10 phosphate buffers and 0.4 cc. of 
varying concentrations of crystalline trypsin as indicated in Table III.  At the 
intervals  there  shown,  aliquot  portions  of  each  solution  were  withdrawn  and 
tested for thrombin activity by adding varying quantities to a  fixed amount of 
similarly buffered fibrinogen and noting the coagulation time (cf. page 545). 
TABLE  III 
The Effect of pH on the Formation of Thrombin from Prothrombin by Trypsin 
Crystalline 
trypsin, 
l/Is 
per cent 
0.4 
0.35 
0.3 
0.25 
0.2 
0.175 
0.4 
0.35 
0.3 
0.25 
0.2 
0.175 
0.4 
0.35 
0.3 
0.25 
0.2 
0.175 
Time  I 
interval 
5 
15 
90 
8.3 
ot 
0 
0 
1A 
9 
4 
0 
0 
0 
3 
L2.2 
3.2 
0 
0 
0 
0 
L5 
Relative amount* of thrombin formed at pH 
7.4 
0 
0 
0 
8 
13 
3.5 
0 
0 
0 
10 
18 
3 
0 
0 
0 
1.5 
22.5 
7.1 
0 
2.5 
12.5 
12.5 
10 
3 
0 
0 
7.5 
15.0 
17.5 
2.5 
0 
0 
0 
2.5 
22.5 
6.8 
0 
3 
26 
35 
12 
3 
0 
0 
30 
60 
16 
2.5 
0 
0 
1.5 
15 
25 
6.5 
3O 
25 
2O 
10 
1., 
0 
26 
45 
68 
17.. 
2.1 
0 
0 
3 
30 
25 
6.2 
~8 
15 
18 
17.5 
8 
2.0 
27.5 
50 
25 
12 
2.0 
0 
0 
10 
22 
22.5 
,9 
0 
0 
:8 
:8 
:7 
ol 
0 
0 
40 
30 
6 
0 
0 
0 
15 
50 
12 
3 
5.6 
0 
0 
0 
<10 
<10 
0 
0 
0 
<2O 
<2O 
0 
0 
0 
<20 
42 
<20 
0 
* The amount  formed from the same prothrombin  by  Ca and  tissue 
is taken as 200. 
t  Less than 1 on the arbitrary scale. 
Soft clots or shreds form instead of a solid clot. 
extract 
In estimating the thrombin content of the solutions, it was necessary to take 
into  consideration  the  fact  that  the  coagulation  time  obtained  with  a  given 
amount  of  thrombin  varies  with  the  pH.  Accordingly, a  series  of  reference 
curves was constructed, correlating the coagulation time with thrombin concen- 
tration at the various pH levels used in the actual experiment; and the thrombin 
content of a given solution was obtained by interpolating the observed coagulation 
time on the appropriate reference curve. HARRY  EAGLE  AND  TZVEE  N.  HARRIS  553 
in  less  than  optimum  concentrations  to  some  prothrombin,  and 
obtains, e.g. a  20 per cent yield of coagulant; and if one then adds Ca 
and tissue extractive, the total amount of coagulant formed is exactly 
the  same  as would have  been  formed by  the  Ca  and  tissue  factor 
alone.  Conversely,  trypsin  added  to  formed  Ca-thrombin  (a  pro- 
thrombin-Ca-tissue  extract  mixture)  has  no  effect  other  than  to 
digest the coagulant if added in excess. 
Clearly,  trypsin  and  the  Ca-tissue  (or  Ca-platelet)  system  are 
mutually supplementary, and affect the same substrate, prothrombin, 
to  form  as  end  products  coagulants  which  are  qualitatively  indis- 
tinguishable.  As has already been  shown, the fact that the amount 
Protocol 3 
The coagulation  of blood in rivo by trypsin. 
1.  10 cc. of a 5 per cent solution of crude trypsin were injected intravenously 
into a rabbit weighing approximately  2 kg.  The animal died in convulsions in 
2 minutes, and large clots were found in the great veins 2 minutes after death. 
2.  1 cc. portions of a 5 per cent solution of crude trypsin were injected into a 
rabbit at 10 minute intervals.  11/~  minutes after the fourth injection it began to 
convulse, and was dead 1 minute later.  On autopsy 6 minutes later the right 
ventricle and both auricles were found filled with a solid clot. 
3.  10 cc. of 5 per cent trypsin were injected intravenously into a rabbit.  5 sec- 
onds later, the animal began to convulse, and died within 2 minutes.  The heart, 
opened 3~ minutes after death, contained a solid clot in every chamber except 
the left ventricle,  which was fibrillating.  Blood obtained from the great veins 
would not clot, and no precipitate was obtained either on heating the plasma at 
56°C. for 5 minutes, or on the addition of 1.5 volumes of saturated NaC1. 
of  thrombin  formed  from prothrombin at the optimum trypsin con- 
centration is usually less than that elaborated by the addition of Ca is 
due to the  rapid digestion of the formed thrombin by the  trypsin. 
Prothrombin -t'- Ca  7  r-----> 
Prothrombin -b  platelets (tissue extractive) 
Prothrombin +  (Ca-platelets)  ----->  thrombin 
Prothrombin -b  trypsin  ----->  thrombin 
The  implications  of  this  analogy  are  discussed  on  page  557. 
Whether trypsin, as a proteolytic enzyme, hydrolyzes prothrombin to 
form thrombin,  or  whether  trypsin  combines with prothrombin  to 554  BLOOD  COAGULATION.  V 
form  a  new  enzyme,  thrombin,  must  be  left  unanswered  for  the 
present  (cf.  page 557). 
As is described in  Protocol 3,  trypsin injected intravenously into 
rabbits causes almost immediate death.  Large blood clots are found 
in the heart and large vessels; the free fluid is  non-coagulable, and 
contains no demonstrable fibrinogen.  Trypsin thus seems to initiate 
blood coagulation in vivo as readily as it does in vitro. 
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content: but the enzyme as such coagulates fibrinogen.  The prothrombin used 
in  this  experiment was  the acetic acid precipitate heated  at  56°C.  to  remove 
fibrinogen (of.  page 544), and contained su/ficient platelet material to be activated 
to thrombin by the addition of Ca alone.  The  oxalated  papain  solution  con- 
tained 0.016 M sodium oxalate, and was centrifuged free of the precipitated Ca 
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The Coagulation  of Blood or Plasma by Papain 
In view of the results obtained with trypsin, it became of interest 
to ascertain whether other proteolytic enzymes had a  similar effect. 
Papain, the enzyme present in the juice of the papaw, was accordingly 
tested, and was found to be active.  Unlike trypsin, however, papain HARRY  EAGLE  AND  TZVEE  lq.  lqARRIS  555 
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as  such does not  activate  prothrombin  to  thrombin,  but  does  act 
directly on fibrinogen to form a  fibrillar gel resembling fibrin.  As 
one  repeatedly  precipitates  and  redissolves  fibrinogen,  it  becomes 
progressively less coagulable by either Ca -t- platelets or by trypsin, 
because of the rapid and eventually complete removal of prothrom- 
bin;  but  its  coagulability by  papain  is  unaffected  (Table  IV).  It 
should be pointed out that the crude enzyme powder contains large 
quantities  of  calcium,  and  accordingly  activates  prothrombin  to 
thrombin.  However, if the Ca is removed by the addition of oxalate 
or  citrate,  papain  no longer activates prothrombin,  but  retains its 
coagulative action on fibrinogen quantitatively (Fig. 4). 
The clots formed by the action of papain are relatively soft, par- 
ticularly when high concentrations of  the  enzyme are used; and in 
that range one observes a  rapid re-solution of the clot analogous to 
the slow fibrinolysis occasionally observed after physiological coagula- 
tion. 
DISCUSSION 
I. Crystalline trypsin has been found to activate prothrombin to 
thrombin.  The available data offer  no clue  as to whether the pro- 
thrombin  is merely  hydrolyzed,  or whether  the enzyme  actually 
combines with prothrombin  to form a modified enzyme, thrombin. 
The minute amounts of trypsin which suffice  are wholly compatible 
with a theory of stoichiometric combination.  Thus, 0.003 cc. of a 
0.04 per cent solution of crystalline  trypsin activated 1 cc. of a pro- 
thrombin  solution containing  0.04 per cent protein.  The  trypsin: 
protein ratio was approximately  1:300;  but since the actual pro- 
thrombin  in a so called prothrombin  solution is probably  a very 
small fraction of the total solids  present, the trypsin: prothrombin 
ratio in this  experiment may well have been 1:50, 1:5,  or even I:I. 
2. The terms cytozyme, thrombozyme,  and thrombokinase  which 
have been applied to the platelet  (or tissue)  factor  by various investi- 
gators express their belief  that this factor functions as an enzyme 
in the activation of prothrombin to thrombin.  The only objective 
evidence hitherto presented in support of this  hypothesis is (a) the 
minute amount of platelets  or tissue  extractive which suf~ces  to pro- 
duce a maximum  yield of thrombin, and (b) the fact that further ]lAItY  EAGLE  AND  TZVEE  N. IIARRIS  557 
increase  in  the  amount  of  platelets  merely  accelerates  thrombin 
production and does not affect the quantity formed (Eagle  (1935 a)). 
The present experiments show that trypsin has the same activating 
effect on  prothrombin as  the  physiological system,  Ca  +  platelets 
(or  Ca  +  tissue  extracts).  It  is difficult to  conceive of  so  specific 
a  phenomenon as  the  transformation  of  prothrombin  to  thrombin 
being effected by two wholly dissimilar mechanisms.  We  therefore 
suggest as  a  tentative  working hypothesis that  Ca  -t-  platelets  to- 
gether constitute a  proteolytic enzyme analogous to trypsin, 1 which 
reacts with prothrombin to form thrombin.  As in the case of trypsin, 
there  is no  experimental evidence which justifies  a  choice between 
the  theory  that  the  platelets  combine  with  prothrombin  to  form 
thrombin,  and  the  alternative  possibility  that  the  transformation 
merely involves enzymic hydrolysis. 
We  have  been  unable  to  demonstrate  any  proteolysis  (formol 
titration)  during  the  Ca-platelet-prothrombin  reaction:  but  it  is 
entirely possible that  such proteolysis occurs and escapes detection 
because of the minute molecular concentration of actual prothrombin 
in  the  preparations  used. 
3.  The effect of trypsin here described has several other important 
implications.  Howell  and  Fuchs  maintain  that  prothrombin  is 
present in circulating blood as an inactive heparin-prothrombin com- 
pound;  that  platelets  combine with  heparin  and  thus  release  free 
prothrombin;  and  that  this  free prothrombin  then  reacts  with  Ca 
to form thrombin.  ~  The present experiments clearly  show that  Ca 
is not  necessarily  an  intrinsic  part  of  thrombin,  for  trypsin  reacts 
directly with prothrombin to form thrombin in its complete absence. 
Again, according to the theory of Howell and Fuchs, platelets or tissue 
extracts  mobilize  prothrombin  from  its  hypothetical  union  with 
heparin, and should therefore increase the rate and degree of thrombin 
production, whether one uses Ca or trypsin as the activating agent. 
As is illustrated  in Table  II,  however,  tissue  extracts  have  no  de- 
monstrable  effect on  the  rate  or  degree  of  thrombin  formation by 
t The postulated platelet enzyme is dearly not trypsin as such: for trypsin 
rapidly digests formed thrombin, while Ca and platdets have little or no effect. 
2 According to Fuchs, platelets function both in the hypothetical mobilization 
of prothrombin, and in the subsequent reaction with calcium. 558  BLOOD  COAGULATION.  V 
trypsin;  and  similar results  have been  obtained on  using platelets 
instead of tissue extracts.  It would therefore seem that the latter 
reagents  do  not  function  physiologically  by  freeing  prothrombin 
from  a  hypothetical union with  heparin.  It  is  significant in  this 
connection that trypsin injected intravenously coagulates circulating 
blood as readily as it coagulates plasma in vitro;  the prothrombin of 
circulating blood is apparently free and reactive.  There are other 
reasons to doubt that heparin is of physiologic significance in prevent- 
ing intravascular  coagulation  (Quick; Mellanby  (1935 a);  Eagle,  in 
preparation); and taken in conjunction with the experiments cited, 
they render the heparin theory improbable. 
By the same token, the fact that  trypsin can cause intravascular 
coagulation, seems to invalidate the theory of Bordet that circulating 
blood  contains, not prothrombin as such, but an inactive precursor 
which becomes reactive only on  contact with  some foreign surface, 
such as glass. 
4.  A  second proteolytic enzyme, papain,  was  found to  have  no 
effect on  prothrombin other  than  its  digestion, but  was  found to 
act directly on fibrinogen to form a fibrillar gel resembling fibrin.  If 
one considers this product to bear only a  superficial resemblance to 
fibrin, then the phenomenon is of no significance as regards physio- 
logical coagulation; but if the clot formed by papain is identified as 
fibrin, it becomes probable that thrombin, like papain, is a proteolytic 
enzyme. 
This  was  the  theory  originally  proposed  by  Schmidt  in  1872; 
and the present experiments indicate that it is still the most saris- 
factory working hypothesis as to the mechanism of thrombin action 
(cf. Eagle (1935 b)). 
5.  Experiments  now  in  progress  indicate  that  the  coagulating 
activity of proteolytic enzymes offers an adequate and simple explana- 
tion for the well known but hitherto unexplained observations that 
certain bacteria and certain snake venoms can cause plasma to coagu- 
late:  and  they  suggest a  new attack  (leucocytic enzymes)  on  the 
mechanism of fibrin deposition at  sites of inflammation. 
6.  It  is  to  be  noted  that  the  recently  discovered activation  of 
chymo-trypsinogen by trypsin, with the formation of chymo-trypsin HARRY  EAGLE  AND  TZVEE  N.  HARRIS  559 
(Kunitz  and Northrop),  offers a complete analogy for the mechanism 
of physiological coagulation as here suggested: 
Substrate  Activating 
proteolytic enzyme  Product, a proteolytic enzyme 
Chymo-trypsinogen -4-  Trypsin  ~  Chymo-trypsin 
fl  rypsin  a-platelets 
Ca-tissue extracts 
Snake venoms* 
acterial proteases* 
Prothrombin  -I-  Thrombin, a proteolytic enzyme 
analogous to papain and certain 
snake  venoms*  in  that  it con- 
verts fibrinogen to fibrin. 
* To be discussed in following papers. 
SUMMARY 
Crude or crystalline  trypsin in proper concentration causes  the 
blood or plasma of human beings, dogs,  rabbits,  guinea pigs,  and 
horses to coagulate.  It does not dot the fibrinogen  directly,  but 
reacts  with prothrombin to form thrombin.  Since  trypsin thus has 
the same effect  as the physiological  system Ca plus  platelets  (or Ca 
plus  tissue  extracts),  it  is  suggested  as  a tentative  working  hypothesis 
that the latter  system contains  a proteolytic  enzyme with a specific 
affinity  for prothrombin.  Other implications  of this trypsin  effect 
with respect  to the mechanism of physiological  coagulation  are dis- 
cussed  in the text  (pages  55?-558). 
The proteolytic  enzyme papain also coagulates blood.  In this 
case the enzyme does not activate  prothrombin, but acts  directly  on 
fibrinogen  to form a fibrillar  gel  resembling  fibrin.  If  one admits  this 
dot to be fibrin,  this  constitutes  strong  evidence  that thrombin, the 
physiological  coagulant,  is also  a proteolytic  enzyme with a spedfic 
action on fibrinogen. 
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